- Ablynx, Karen Heyninck
- Abzena, Campbell Bunce
- Amgen, Dan Mytych
- AstraZeneca, Jo Goodman
- Bayer, Pedro Paz
- BioAgilytix Europe, Arno Kromminga
- Boehringer Ingelheim, Patrick Garidel
- Celerion, Patrick Brennecke
- Covance, James Munday
- Fresenius Kabi, Martin Ullmann
- Genmab, Arnout Gerritsen
- GlaxoSmithKline, Stephen De Wall
- Hansa Biopharma, Yvonne Stenberg
- ImmunXperts, Sofie Pattijn
- Integrated Biologix GmbH, Sebastian Spindeldreher
- Kamondi Bioanalytical Consultancy GmbH, Szilard Kamondi
- LGC, Deborah McManus
- Lonza, Noel Smith
- Lundbeck, Lars Ostergaard Pedersen
- Merck Group KgaA, Mantas Malisauskas
- MSD, Vibha Jawa
- Novartis, Claudio Calonder
- Novimmune, Laetitia Sordé
- Novo Nordisk, Hélène Solberg
- Pfizer, Tim Hickling
- Pharming, Beatrijs Oortwijn
- QPS, Veronique Putman
- Roche, Gregor Lotz
- Sandoz, Anita Rudy
- Sanofi, Daniel Kramer
- Sanquin, Theo Rispens
- SciPot Consultancy, Melody Janssen
- Shire, Birgit Reipert
- Swedish Orphan Biovitrum AB, Nina Brenden
- Thermo Fisher Scientific, Åsa Marknell DeWitt
- UCB Pharma, John Smeraglia
- Wieslab, a Svar Life Science company, Janka Ryding